X0306 4 2019-03-28 1 0001624899 STERIS plc STE 0001697095 Burton Karen L C/O RUTHERFORD HOUSE, STEPHENSONS WAY CHADDESDEN DERBY X0 DE21 6LY UNITED KINGDOM 0 1 0 0 VP, Controller & CAO Ordinary Shares, 10 pence par value 2019-03-28 4 D 0 8404 D 0 D Employee Stock Option (right to buy) 36.09 2019-03-28 4 D 0 3800 D 2021-05-31 Ordinary Shares 3800 0 D Employee Stock Option (right to buy) 29.94 2019-03-28 4 D 0 3700 D 2022-05-30 Ordinary Shares 3700 0 D Employee Stock Option (right to buy) 45.34 2019-03-28 4 D 0 4040 D 2023-05-31 Ordinary Shares 4040 0 D Employee Stock Option (right to buy) 53.52 2019-03-28 4 D 0 3400 D 2024-05-30 Ordinary Shares 3400 0 D Employee Stock Option (right to buy) 66.15 2019-03-28 4 D 0 2852 D 2025-05-28 Ordinary Shares 2852 0 D Employee Stock Option (right to buy) 69.72 2019-03-28 4 D 0 2600 D 2026-06-01 Ordinary Shares 2600 0 D Employee Stock Option (right to buy) 77.07 2019-03-28 4 D 0 4000 D 2027-05-30 Ordinary Shares 4000 0 D Employee Stock Option (right to buy) 114.22 2019-03-28 4 D 0 7900 D 2028-05-31 Ordinary Shares 7900 0 D 7,016 of these ordinary shares are restricted and vest as follows: 764 on May 28, 2019; 700 on October 1, 2019; 1,220 on June 1, 2020; 3,000 on June 1, 2021; and 1,332 on May 31, 2022. Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,800 ordinary shares of STERIS for $36.09 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,700 ordinary shares of STERIS for $29.94 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,040 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,400 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option becomes exercisable as follows: 713 on May 28, 2016, 713 on May 30, 2017, 713 on May 29, 2018 and 713 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 2,852 ordinary shares of STERIS for $66.15 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option becomes exercisable as follows: 650 on June 1, 2017, 650 on June 1, 2018, 650 on June 3, 2019 and 650 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 2,600 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option becomes exercisable as follows: 1,000 on May 30, 2018; 1,000 on May 30, 2019; 1,000 on June 1, 2020 and 1,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option becomes exercisable as follows: 1,975 on May 31, 2019; 1,975 on June 1, 2020; 1,975 on June 1, 2021 and 1,975 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,900 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. /s/ Ronald E. Snyder, Authorized Representative under Power of Attorney 2019-03-28